A novel strategy for the controlled release and localization of bioactive peptides within digestive and immunityrelated enzymes was developed. The N-terminus of porcine pepsinogen A was fused to the basic amino acidrich region of bovine lactoferricin B termed 'tLfcB', a cationic antimicrobial/anticancer peptide. Recombinant tLfcB-porcine pepsinogen A was expressed in soluble form in Escherichia coli as a thioredoxin (Trx) fusion protein. Thioredoxin -tLfcB-porcine pepsinogen A was found to activate autocatalytically under acidic conditions. Recombinant pepsin A derived from the activation of the fusion protein had a catalytic rate and substrate affinity similar to that derived from the recombinant thioredoxin-porcine pepsinogen A control. Pepsintreated thioredoxin -tLfcB-porcine pepsinogen A yielded increased antimicrobial activity against the Gramnegative bacteria E.coli relative to control suggesting that a second function (antimicrobial activity) was successfully engineered into a functional peptidase. The novel design strategy described herein presents a potential strategy for targeted delivery of antimicrobial or therapeutic peptides in transgenic organisms via re-engineering native proteins critical to plant and animal defense mechanisms.
Introduction
Information on structure-function relationships has been utilized for improvement of specific enzyme characteristics such as folding, stability, substrate specificity, enantioselectivity and catalytic activity (Brannigan and Wilkinson, 2002) . The redesign of enzymes with new or altered functions remains a challenge (Gaseidnes et al., 2003) with two complementary enzyme engineering strategies available; rational design and directed evolution (Chen, 2001 ). The present rational design study sought to engineer a multifunctional enzyme [an aspartic peptidase (AP)] to serve as both carrier and delivery mechanism of a functional peptide [an antimicrobial peptide (AMP)]. APs, EC 3.4.23.X, are characterized by the presence of two catalytic aspartic acid residues localized within two short amino acid stretches that share sequence homology, similar threedimensional structure, low optimal pH value, a scission preference between hydrophobic amino acids and inhibition by the microbial peptide pepstatin (Davies, 1990; Blundell and Johnson, 1993) . Although most APs conform to these characteristics, substantial differences exist in their properties, cellular localization and biological functions (Koelsch et al., 1994) .
A very well-studied AP, pepsin A (EC 3.4.23.1), belongs to the A1 AP family (MEROPS classification; http://merops. sanger.ac.uk; Rawlings et al., 2006) . In vivo, the precursor form of pepsin A is synthesized and folded as a zymogen, pepsinogen A (PG), at neutral pH in the gastric mucosa of vertebrates. PG contains an N-terminal, 44-residue peptide referred to as the prosegment (James and Sielecki, 1986 ) that is removed under acidic conditions yielding active pepsin, a single polypeptide chain of 323 residues. Pepsin consists mainly of b-sheet and its tertiary structure is bilobal consisting of two similar domains in which each domain contributes a catalytic aspartic acid residue located at the bottom of an inter-domain cleft (Sielecki et al., 1990) . Previously, engineering of recombinant PG has exhibited altered activation and stability profiles: N-terminal mutations in pepsin designed to introduce the cathepsin D Lys-X-Tyr motif resulted in increased neutral pH stability (Bryksa et al., 2003) ; N-linked glycosylation of four pepsin mutants resulted in increased structural rigidity and structural stability (Yoshimasu et al., 2004) ; A chimeric AP containing PG and the plant-specific sequence derived from Arabidopsis thaliana AP resulted in increased pH-and temperature-stability (Payie et al., 2003) .
AMPs offer huge potential therapeutic value for both animals and humans due to their activity against pathogens resistant to traditional antibiotics, and some display anticancer/antiviral activity (Hancock and Lehrer, 1998; Farnaud and Evans, 2003; Mader et al., 2005; Hoskin and Ramamoorthy, 2008; Jenssen and Hancock, 2009) . Some AMPs are active against plant pathogen fungi (Terras et al., 1995; Guevara et al., 2004) as well as animal pathogen fungi making such peptides potentially important to crop engineering endeavors and animal husbandry, respectively. Additionally, investigations of AMPs derived in food-related systems are an ongoing area of interest due to the potential for conferring enhanced antipathogen activities to products (Meisel, 2005; Hayes et al., 2006; Korhonen and Pihlanto, 2006) .
In addition to human health interventions, natural plant defence mechanisms against plant pathogens (fungi) include the expression of APs (Schaller and Ryan, 1996; Guevara et al., 2005) and developing new, ecofriendly strategies for protecting plants against pests and pathogens are currently one of the most dynamic areas of research in plant science (Kim et al., 2009 ). The use of pesticides and/or constitutively expressed, recombinant proteins, e.g. BT, which significantly impact on non-target soil microbe ecology (Castaldini et al., 2005) , could potentially be minimized by engineering immunity-related proteins to contain enhanced antipathogen activity. Additionally, animal bacterial infections are a major cause of calf mortality (Tsolis et al., 1999) in addition to being human food pathogen risks, e.g. Escherichia coli O157:H7 risks, which are presently addressed by exposure reduction, exclusion strategies and antipathogen treatments including antibiotics (LeJeune and Wetzel, 2007) as well as a recently approved E.coli O157:H7 vaccine for cattle (Potter et al., 2004) . In contrast, immunity enhancement via feed and the GI tract is a proven concept as evidenced by the success of probiotic additives to animal feed (LeJeune and Wetzel, 2007) . Oral administration of lactoferrin exerts various health beneficial effects including anti-infective activities in both young and adult animals (Wakabayashi et al., 2006) .
The present study tests the effect on protease function of fusing a bioactive peptide to the N-terminus of the zymogen porcine pepsinogen A (the archetypal model AP). The basic amino acid-rich region of lactoferricin B (tLfcB) antimicrobial sequence was chosen as the model peptide since lactoferricin B (LfcB) is naturally derived via pepsin digestion of lactoferrin in the gut (Tomita et al., 1991) ; thus proteolytic degradation of the peptide moiety would not be expected in a delivery system that employs pepsin as the carrier/releasing molecule. Thioredoxin (Trx) was selected as a fusion partner due to its ability to improve the solubility of recombinant, soluble APs (Tanaka and Yada, 1996; Xiao et al., 2006 Xiao et al., , 2007 , and it has been used for soluble expression of an AMP, magainin, in a manner that protected host cells from toxic effects (Barrell et al., 2004) . Immunity-related peptidases engineered to contain enhanced antipathogen functionalities thus represent a novel strategy to reduce traditional antibiotic and pesticide use in a non-constitutive expression scenario thereby minimizing human contact and consumption. Therefore, the characterization of AP function post-activation and relative peptide activity upon fusion protein activation were examined to evaluate the success of this first approach to zymogen-mediated bioactive peptide delivery.
Materials and methods

Materials
The plasmid pET32b(þ) and E.coli Rosetta-gami B (DE3)pLysS were obtained from EMD Biosciences (San Diego, CA, USA). Escherichia coli TOP10F' was from Invitrogen (San Diego, CA, USA 
Construction of expression vectors pET-tLfcB-PG and pET-PG
A 7034-bp construct termed 'pET-tLfcB-PG' was made for the soluble expression of thioredoxin -lactoferricin B fragment -pepsinogen A fusion protein (Trx-tLfcB-PG) in E.coli. The construct uses the vector pET32b(þ) endogenous KpnI and HindIII sites for ligation of the 5 0 tLfcB end to the 3 0 PG end, respectively. The 3 0 tLfcB end and the 5 0 PG end were joined at a unique XmaI site. Two overlap-extension oligonucleotides were designed to encode for tLfcB to be fused between Trx and PG: tLfcBFwd 5 0 -GAGGTACCAAACC GGCGAAATTTTTTCTGCTGCGTCGTTGGCAGTGGCGT ATGAAAAAACTG and tLfcBRev 5 0 -AGCCCGGGCAGC AGAAAAAATTTCGCCGGTTTGCCCAGTTTTTTCATAC GCCACTGCCAACG. tLfcB consisted of the core LfcB AMP sequence RRWQWRMKKLG (Kang et al., 1996) flanked on each end by the optimal PG cleavage sequence KPAKFFLL (Dunn and Hung, 2000) . All tLfcB codons were optimized for expression in E.coli. PG containing 5 0 XmaI and 3 0 HindIII sites was generated by PCR using primers PGFwd 5 0 -NCC CGGGGCCCTGATCGGCATGCTCGTCAAGGTCCCGCTG and PGRev 5 0 -TATAAGCTTGGCCACGGGAGCCAGGCCG. Vector, tLfcB overlap-extension product and PG PCR product were ligated at once in a three piece ligation reaction yielding engineered Trx-tLfcB-PG (Fig. 1) . The pET-tLfcB-PG was transformed into E.coli TOP10F' using the method of Hanahan (1983) .
For construction of pET-PG, porcine PG was fused with Trx as follows: PG cDNA was amplified from the E.coli expression plasmid pTrxPg (Tanaka and Yada, 1996; Bryksa et al., 2003) using primers KpnIFwd 5 0 -ATCGGTACCCTC GTCAAGGTC-3 0 and HindIIIRev 5 0 -TATAAGCTTGGC CACGGGAGCCAGGCCG-3 0 . The PCR product was then subcloned into pET32b(þ), resulting in plasmid pET-PG. Sequences were verified by Laboratory Services Division, University of Guelph (Guelph, ON, Canada).
Protein expression and purification
Overnight cultures of E.coli Rosetta-gami B (DE3)pLysS cells transformed with pET-PG or pET-tLfcB-PG were used to inoculate 1 l cultures of Luria -Bertani broth containing 50 mg ml 21 ampicillin, 12.5 mg ml 21 tetracycline, 15 mg ml 21 kanamycin and 34 mg ml 21 chloramphenicol. Cultures were grown at 378C, 250 rpm until an OD 600 of 1.0 was reached. The cells were induced with 1 mM isopropyl b-D-1-thiogalactopyranoside (IPTG) and further incubated for 8 h at 308C. Cells were harvested by centrifugation at 4500g for 10 min at 48C and stored at 2208C until further use. Frozen cells were thawed at RT and resuspended in 25 ml of 50 mM sodium phosphate buffer pH 7.5 containing 0.6% chicken lysozyme. Suspensions were incubated at room temperature (RT) for 2 h with gentle shaking. Cell lysates were centrifuged at 16 000g for 30 min at 48C to isolate the soluble fraction.
Protein purification was performed using an AKTA TM FPLC system (GE Healthcare). Lysate supernatants were applied on a 6.4-ml HIS-Select w High Flow cartridge equilibrated with loading buffer 300 mM NaCl, 20 mM imidazole in 50 mM sodium phosphate, pH 7.4. The column was then washed with loading buffer until a steady baseline was obtained and recombinant fusion protein samples were eluted with 300 mM NaCl, 250 mM imidazole in 50 mM sodium phosphate pH 7.4. Eluent was dialyzed in 20 mM Tris -HCl pH 7.4 and concentrated using an Amicon w Ultra-15 50 000 NMWL centrifugal filter device (Millipore Corp., Bedford, MA, USA). Concentrated fusion protein was applied on an HR 5/5 Mono Q anion exchange column and eluted with a linear gradient of 1 M NaCl in 20 mM Tris -HCl pH 7.4. Fractions containing fusion protein were dialyzed in 50 mM NaCl, 2.5 mM CaCl 2 in 50 mM Tris -HCl pH 8.3 and concentrated using an Amicon w Ultra-15, 30 000 NMWL centrifugal filter device. Fusion protein was digested with thrombin at 378C overnight to cleave fusion protein. Digested samples were diafiltered against 20 mM Tris -HCl pH 7.4 in Amicon w Ultra-15 10 000 NMWL centrifugal filter devices and applied to a HR 5/5 Mono Q anion exchange column. Elution was performed using a linear gradient of 1 M NaCl in 20 mM Tris -HCl pH 7.4 yielding pure recombinant PG or tLfcB-PG.
Autoactivation of Trx-PG and Trx-tLfcB-PG
In order to obtain recombinant pepsin (r-pepsin), zymogenic, recombinant proteins were activated by adding 0.1 vol. 0.8 N HCl at RT for 1 h. Samples were then neutralized with a 0.5 vol. 1 M sodium acetate pH 5.3 as per Yoshimasu et al. (2004) . Activated samples were applied to a HR 5/5 Mono Q anion exchange column and eluted with a linear gradient of 1 M NaCl in 20 mM sodium acetate pH 5.3.
Kinetic measurements
Kinetic constants for r-pepsin from PG and tLfcB-PG were determined using the synthetic substrate KPAEFF(NO 2 )AL, where the FF(NO 2 ) peptide bond is the site of pepsin cleavage (Dunn et al., 1986; Fusek et al., 1990) , as described previously by Dee et al. (2006) . The substrate was synthesized at the Core Facility for Protein/DNA Chemistry located at Queens University (Kingston, ON, Canada). Reactions were carried out in 100 mM sodium acetate pH 2.1 using 10 nM r-pepsin and 8 -160 mM substrate at 378C. The initial reaction rates (2DA/min) were measured as the linear decrease in absorbance at 300 nm using a Ultrospec 3100 Pro (Biochrom, Cambridge, England). Kinetic constants for r-pepsins were obtained by non-linear curve fitting in GraphPad (GraphPad Software Inc., La Jolla, CA, USA) to the Michaelis -Menten equation. Each sample was done in triplicate for each substrate concentration. The active site concentrations of r-pepsin samples from PG and tLfcB-PG were determined by pepstatin A titrations.
Mass spectrometry
Peptide sequence analysis was performed at the Advanced Protein Analysis Center (The Hospital for Sick Children, Toronto, ON, Canada). Briefly, samples were reduced with DTT, and Cys residues were alkylated using iodoacetamide. Samples were digested with sequencing grade trypsin (Promega Co.). Resulting peptide products were separated by C18 reversed-phase chromatography (Magic C18, Michrom BioResources, Sacramento, CA, USA) on an EASY n-LC (Proxeon Biosystems, Odense, Denmark) using a 0 -40% acetonitrile gradient in line with a linear ion trap mass spectrometer (LTQ, ThermoFisher, San Jose, CA, USA) operated 0 lactoferricin end and the 3 0 pepsinogen end were ligated into vector pET32b KpnI and HindIII sites, respectively, in a three-fragment ligation reaction. An XmaI site was introduced for ligation of the 3 0 lactoferricin end and the 5 0 pepsinogen end as described in the 'Materials and Methods' section. LfcB antimicrobial fragment (bold) is flanked on each end by an optimal pepsin cleavage site (italics).
Rational redesign of porcine pepsinogen containing an AMP in a data-dependent mode. Raw data were processed with the Mascot search engine (Matrix Sciences, London, UK) with a fragment ion mass tolerance of 3.0 Da. Iodoacetamide derivative of cysteine was specified in Mascot as a fixed modification. Scaffold (version 2_05_00, Proteome Software Inc., Portland, OR, USA) was used to validate MS/MS-based peptide and protein identifications. Peptide identifications were accepted if they could be established at a greater than 50.0% probability as specified by the Peptide Prophet algorithm (Keller et al., 2002; Nesvizhskii et al., 2003) and contained at least two identified peptides. Proteins that contained similar peptides and could not be differentiated based on MS/MS analysis alone were grouped to satisfy the principles of parsimony.
Measurement of antimicrobial activity
Fusion protein samples of 1 mg ml 21 were incubated in 73 mM HCl and 10 mM commercial pepsin for 1 h at 378C. Activation was stopped by neutralizing via addition of 0.5 vol. 1 M Tris -HCl pH 7.4. The antimicrobial activities of digested samples were measured by the optical density of the cultures in microplates using a modified 2-fold microtiter broth dilution method (Wu and Hancock, 1999) . Non-pathogenic E.coli TOP10F' was used as an indicator organism similar to Kim et al. (2006) . An overnight culture in Muller Hinton broth (DIFCO, Detroit, MI, USA), pH 7.3, was diluted to give 2 Â 10 5 cfu ml
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. A total of 110 ml of bacteria suspension was dispensed into each well of a sterile 96-well Costar polypropylene microtiter plate (Fisher Scientific, Ottawa, ON, Canada). Eleven microlitres of digested Trx-tLfcB-PG or Trx-PG control was added to each well and incubated at 378C for 18-24 h in triplicate. After incubation, the microplate was shaken for 10 s and OD 600nm was measured using a BioTek Synergy TM HT multi-detection microplate reader (Bio-Tek w Instruments, Winooski, VT, USA). The activity of commercial tLfcB (fragment 4 -14 trifluoroacetate salt, RRWQWRMKKKLG; Sigma-Aldrich) was used as a positive control.
SDS-PAGE and Western blot analysis
Tris-glycine buffered SDS -PAGE was conducted according to the method of Laemmli (1970) in a Mini-Protean III electrophoresis cell (Bio-Rad, Hercules, CA, USA). Tris-tricine buffered SDS -PAGE was conducted according to the method of Schagger and von Jagow (1987) . The separated proteins were either stained with Gel-Code Blue w (Fisher Scientific) or transferred onto PVDF membrane (Bio-Rad) for blotting using either rabbit anti-His 6 antibody (Immunology Consultants Laboratory Inc., Newberg, OR, USA) or rabbit anti-porcine pepsin A antibody which was produced by our laboratory, each at 1:5000 dilutions. Electroblotting was carried out for 1 h at constant voltage (100 V, 48C) in a Mini Transblot electrophoretic transfer cell (Bio-Rad).
Protein concentration determination
Protein concentrations were determined using the Bio-Rad Dc Protein Assay (Bio-Rad Laboratories) and standard curves were generated using bovine serum albumin (Fisher Scientific).
Statistical analyses
Statistical analyses were performed using GraphPad with one-way analysis of variance (ANOVA) followed by the Tukey -Kramer multiple comparison tests.
Results and discussion
Construction and expression of Trx-PG and Trx-tLfcB-PG
In the present study, tLfcB was chosen as a model bioactive peptide because (i) LfcB is resistant to acid protease cleavage; (ii) it is extensively researched and relevant to food systems (Tomita et al., 1991) ; and (iii) it is comprised of a b-sheet joined by a single disulfide bond (Kang et al., 1996) , characteristics suitable for expression in a soluble AP expression system. An initial attempt to express and purify Trx-tLfcB-PG using the ThioFusion Expression System TM (Invitrogen, Carlsbad, CA, USA) as per the manufacturer's instructions using a construct generated in a similar fashion to that described in the 'Materials and Methods' section for the pET system proved unsuccessful due to low yield. No discernable band corresponding to the expected molecular weight was detected by Coomassie-stained SDS-PAGE in crude, soluble extract and only a faint band was observed by rabbit anti-porcine pepsin A Western blot (data not shown). Further downstream purification steps (anion exchange, size exclusion, reversed-phase chromatography) resulted in the loss of detectable target protein (data not shown). To facilitate expression and purification in all further work the pET Expression System described in the 'Materials and Methods' section was used. This system was selected for the following reasons: (i) the tightly regulated T7 promoter is incorporated to prevent transcription of the target gene pre-induction, (ii) it provides the option of using host strains that encode for rare tRNA's and (iii) it includes a His 6 affinity tag to maximize soluble fusion protein yield (as per the manufacturer). A synthetic gene for tLfcB flanked by pepsin cleavage sequences was constructed using an overlap-extension reaction with two overlapping oligonucleotides having codons optimized for E.coli (Fig. 1) . The tLfcB product, along with PCR-amplified PG, were cloned into pET32b(þ) via a triplefragment ligation reaction yielding the pET-tLfcB-PG construct which was subsequently sequenced and transformed into E.coli expression strains BL21 (DE3)pLysS and Rosetta-gami B (DE3)pLysS (RG). Preliminary, qualitative expression tests to determine optimal soluble Trx-tLfcB-PG yields were carried out by varying induction temperature (RT or 308C), induction time (4 or 8 h), IPTG concentration (0.1 or 1 mM), and E.coli strain. Expression from RG induced with 1 mM IPTG and incubated for 8 h at 308C post-induction yielded the most soluble fusion protein as compared by Coomassie-stained SDS-PAGE (data not shown). Soluble protein extracts of pET-PG and pET-tLfcB-PG expressions are shown in Fig. 2 . A band corresponding to Trx-PG (57 kDa) was clearly visible after 4 h induction, whereas no band corresponding to Trx-tLfcB-PG (61 kDa) was visualized until 8 h induction. A relatively higher level of Trx-PG expression compared with Trx-tLfcB-PG was observed (Fig. 2) suggesting that tLfcB slightly decreased expression. The majority of Trx-tLfcB-PG produced was expressed as inclusion bodies (data not shown).
The inherent challenge presented in expressing AMPs using bacterial systems is that the targets are (by definition) toxic to host cells. Bacterial expression systems have been engineered successfully to sequester AMPs in inclusion bodies using insoluble carrier proteins for subsequent protein refolding and cleavage by an exogenous molecule (Haught et al., 1997; Bryksa et al., 2006; Chen et al., 2006; Pazgier and Lubkowski, 2006; Moon et al., 2007) .
With respect to other APs as AMP carriers, prochymosin was used as an N-terminal fusion partner explicitly for its inclusion body-forming ability when expressed in E.coli thereby sequestering antimicrobial activity and protecting host cells. Cyanogen bromide was used to chemically cleave the fusion protein for peptide release (Haught et al., 1997) . Inteins have also been used as fusion partners for AMP production. Engineering recombinant, self-cleaving fusion proteins is the basis for commercial intein-based expression systems and such a system has been employed in the production of b-defensins (Diao et al., 2007) . Unlike AP zymogen-based or exogenous AP-based cleavage, recombinant intein peptide release in vitro is relatively slow (several hours) and is done on-column during purification by either thiol chemical cleavage or under stringent conditions (Chong et al., 1998; Mathys et al., 1999) . Thus, carrier-peptide fusion proteins designed thus far have not been selfprocessing systems that could be incorporated into complex and/or living systems for bioactive peptide release.
The present study took advantage of using an expression construct containing an affinity (His 6 ) tag which typically increases protein purification efficiency (Arnau et al., 2006) . However, modifications such as adding a tag often result in unacceptably low activity, poor precursor stability, or insolubility (Wood et al., 1999) . Accordingly, the construct used for the present study incorporated an internal affinity tag that was located at the C-terminus of the Trx moiety and to the N-terminal side of the inter-protein linking sequence (vector multiple cloning site). Recently, an LfcB derivative 'LfcinB-W10' was expressed as a soluble fusion protein in E.coli using glutathione-S-transferase as a fusion partner (Feng et al., 2009 ) and b-defensin-2 was expressed previously at a high level using the same expression system as used in the present study (Peng et al., 2004) . Thus, it appears that soluble, bacterial expression of AMPs can be well-mediated by fusion to highly soluble carriers.
Future work should assess whether the location of incorporation and/or peptide length within the fusion protein plays a role in expression level. In general, predicting success for soluble expression of APs in bacterial systems remains elusive. For example, previous work on expressing malarial APs that share 50-79% amino acid-sequence identity (Berry et al., 1999) resulted in relatively high yields for plasmepsin II contrasting with poor results for plasmepsin I and histo-aspartic protease (Xiao et al., 2006 (Xiao et al., , 2007 .
Purification of Trx-PG and Trx-tLfcB-PG
Upon cell lysis, fusion proteins were purified using nickel-affinity chromatography. Isolated fusion protein samples were visualized and identified using SDS-PAGE and Western blotting with either rabbit anti-His 6 antibody or rabbit anti-pepsin antibody (Fig. 3) . Using a step gradient, the column was washed with 15% elution buffer (46 mM imidazole) followed by Trx-tLfcB-PG elution at 250 mM imidazole resulting in 90% purity as determined by SDS-PAGE densitometry. Cleavage of fusion protein to release Trx was desired prior to assessing the r-pepsin biological activity to eliminate the possibility of differential steric or charge effects on activation of Trx-PG and Trx-tLfcB-PG. Thrombin digestion overnight at 378C released PG from Trx-PG and tLfcB-PG from Trx-tLfcB-PG, respectively, as evidenced by the appearance of an apparent 42-kDa band for PG (data not shown) and an apparent 50-kDa band representing tLfcB-PG on Coomassie-stained SDS -PAGE (Fig. 4) . Post-thrombin digestion products were further purified by anion exchange to obtain pure PG and tLfcB-PG.
Activation of Trx-PG and Trx-tLfcB-PG
To investigate whether the fusion protein could auto-activate and release r-pepsin upon acidification, Trx-tLfcB-PG was acidified for 30 min at RT as per Okoniewska et al. (1999) . SDS-PAGE and rabbit anti-pepsin Western blot band shifting indicated that Trx-tLfcB-PG fully auto-activated after 30 min and revealed a pepsin band corresponding to 36 kDa (Fig. 5) . After activation, r-pepsin was further purified by anion exchange to remove Trx and PG prosegment. To verify the correct r-pepsin folding Trx-tLfcB-PG was processed by trypsinolysis at 378C for 30 min. As shown in Fig. 5 , trypsin digestion of Trx-tLfcB-PG yielded PG which was resistant to trypsin treatment indicating correct folding of the protein.
Since pepsin contains only one lysine and two arginine residues in its sequence, tryptic digestion would be expected to retain the intact pepsin portion by hydrolyzing the fused protein in the linker region or in the prosegment region (Tanaka and Yada, 1996) . Thus, r-pepsin could be obtained indirectly via acidification of r-pepsinogen product from trypsinolysis-derived Trx-tLfcB-PG.
Kinetics of activated pepsin
Kinetic properties of r-pepsin derived from PG and tLfcB-PG were determined with synthetic substrate, and kinetic constants K m and k cat , were calculated from nonlinear regression analyses using least-squares best fitting to the Michaelis -Menten model (Table I ). The Michaelis Rational redesign of porcine pepsinogen containing an AMP constant and turnover number measured for r-pepsin from Trx-PG were 93 + 30 mM and 43 + 10 s
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, whereas those for r-pepsin from Trx-tLfcB-PG were 92 + 20 mM and 44 + 3 s 21 , respectively. The differences in binding affinities and cleavage rates for the two r-pepsins were not statistically significant (P . 0.05). The K m and k cat values from commercial pepsin were 100 + 20 mM and 94 + 7 s 21 , respectively, similar to the previously reported values (Tanaka and Yada, 1996; Okoniewska et al., 1999; Bryksa et al., 2003; Dee et al., 2006; Sinkovits et al., 2007) ; therefore, the apparent binding affinities and catalytic rates determined for tLfcB-PG-derived r-pepsin were not noticeably affected by the presence of tLfcB in its prosegment during zymogen folding and activation. For many APs, the prosegment is involved in a number of functions including aiding the correct folding, stabilization and inhibition of the native form, contributing to the pH dependence of activation and intracellular sorting of the zymogen (Shinde and Inouye, 2000) . The requirement of the prosegment for correct folding has also been demonstrated among the various peptidase classes (Baker et al., 1992; Sohl et al., 1998; Derman and Agard, 2000; Bernstein et al., 2003; Jaswal et al., 2005) .
Mass spectrometry
LC/MS confirmed the presence of tLfcB in trypsin-digested fusion protein. LC/MS data were searched against the Trx-tLfcB-PG sequence using a Mascot search of the database assuming trypsin digestion. Scaffold version 2_05_00 was used to validate MS/MS-based peptide and protein identifications (for a review, see Aebersold and Mann, 2003) . Table II summarizes ions found corresponding to the single-charged tryptic ions of RWQWR. The double-charged ion of RWQWR was detected (m/z 416.34) confirming that Trx-tLfcB-PG protein contained the tLfcB antimicrobial sequence RRWQWRMKKLG.
Synthetic tLfcB consisted of the core LfcB antimicrobial sequence RRWQWRMKKLG (Kang et al., 1996) flanked on each end by the optimal pepsin cleavage sequence KPAKFFLL where the peptide bond between the two Phe residues is hydrolyzed (Dunn and Hung, 2000) , as described in the 'Materials and Methods' section. Sequence interpretation and database searching for MS/MS spectra indicated that ion products m/z 695.42 and 768.76 were matched to FFLLR and FFLLPGALIG, respectively (underline indicates pepsin cleavage sequence). Since pepsin contains only one lysine and two arginine residues, trypsin digestion of Trx-tLfcB-PG yielded the identification of 204 of over 570 amino acids identified (coverage 36%). The resistance of r-pepsin to trypsin digestion is in agreement with Tanaka and Yada (1996) .
Antimicrobial activity
Antimicrobial activity assays against E.coli grown at 378C in Mueller -Hinton broth, pH 7.3, were used to test for the biological activity of tLfcB peptide released by the digestion of tLfcB-PG. Low yield of Trx-tLfcB-PG prevented purification of tLfcB upon autocatalytic activation, therefore, antimicrobial activity of the activated samples was assessed without further separation of the PG and/or tLfcB moieties.
Natural source lactoferricin B is a 25-amino acid AMP derived from bovine lactoferrin possessing antimicrobial activity against a wide range of microorganisms including Gram-positive and Gram-negative bacteria as well as fungi (Bellamy et al., 1992) . In the present study, tLfcB antimicrobial activity was tested using a single Gram-negative bacteria as an indicator species due to the limited yield of the protein, an approach employed for LfcB studies previously (Feng et al., 2006; Kim et al., 2006) . In the future, improvement in expression yield will likely improve the study of antimicrobial activity against other organisms.
To validate the antimicrobial assay, commercial tLfcB was determined to have a minimum inhibitory concentration (MIC) of 20 mM (31 mg ml
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) against E.coli, similar to the previously reported value, 22.5 mg ml
, for the same sequence (Kang et al., 1996) , and within the range of 12-25 mM reported for LfcB depending on strain and culture medium (Bellamy et al., 1992) . In a direct, equal mass (85 mg ml 21 ) basis comparison of inhibitory activities of the respective recombinant fusion proteins, pepsin-digested Trx-tLfcB-PG suppressed 42% of E.coli growth, whereas pepsin-digested Trx-PG (control) suppressed only 18% of E.coli growth. Thus, the inclusion of tLfcB increased antimicrobial activity against E.coli by 2-fold, suggesting that the AMP sequence engineered into a functional AP was biologically active. Either pepsin-digested Trx-tLfcB-PG released functional tLfcB peptide upon cleavage of the prosegment yielding antimicrobial activity, or tLfcB remained attached to all or part of the prosegment yielding antimicrobial activity. Regardless of scenario, a novel, secondary function (enhanced antimicrobial activity) was successfully engineered into an AP. Low yield precluding post-activation purification prevented MIC determination for recombinant tLfcB as well as structural characterization. The b-sheet structure of LfcB, thought to confer antimicrobial function, is unique to the free form of the peptide unlike the predominantly a-helix LfcB portion within lactoferrin (Hwang et al., 1998) . Determination of whether tLfcB expressed at the N-terminus of our AP zymogen undergoes a conformation change to assume an active form upon zymogen activation is a structural question for future study.
Previous protein engineering endeavors have produced de novo zymogens of toxic, non-proteolytic enzymes that are not naturally zymogenic: ribonuclease A was circularized with an engineered linker sequence that was cleaved specifically by the malaria protease plasmepsin II (Plainkum et al., The -NH 3 ions result in a loss of ammonia from glutamine residues. B ions are N-terminal charged fragments and Y ions are C-terminal charged fragments of the indicated residues. 2003) and the hepatitis C protease NS3 (Johnson et al., 2006) . In addition, the ADP-ribosyltransferase Vip2, pertinent to engineering western corn rootworm-resistant corn, was 'zymogenized' by addition of a C-terminal peptide sequence that was activated via rootworm protease-mediated cleavage yielding the desired toxic activity upon ingestion by the pest larvae (Jucovic et al., 2008) . The present study is distinct from de novo zymogen engineering in that an aspartic protease was re-engineered to confer a secondary, bioactive function as opposed to engineering activitysequestering via zymogenization.
Conclusions
Trx-tLfcB-PG was successfully expressed as a soluble, folded zymogen in a bacterial expression system, and the novel fusion protein was able to auto-activate upon acidification. Furthermore, pepsin-digested Trx-tLfcB-PG showed antimicrobial activity against the Gram-negative bacteria E.coli. The use of zymogens as auto-activating carriers offers the potential to control bioactive peptide release via natural conditions, e.g. APs are naturally part of host-defense mechanisms upon plant wounding (Schaller and Ryan, 1996; Guevara et al., 2004) . Alternately, endogenous or 'partner' proteases could be employed to release bioactive peptides via engineered cleavage sites within engineered fusion proteins to confer host-defense functionalities, similar to Jucovic et al. (2008) , e.g. AMPs transgenically produced in animal milk (Yarus et al., 1996) would be acted upon by gastrointestinal proteases. Hence, advancing the state of knowledge of de novo, bifunctional protease design could have potential crop engineering or nutraceutical applications with respect to bioactive peptide delivery. This study supports the idea that structure -function relationships observed in nature can serve as a template for the creation of de novo enzymes having tailor-made functionalities.
